1.
Fed Pract
; 32(Suppl 11): 8S-15S, 2015 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30766102
RESUMO
SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A1c-lowering effects while inducing weight loss without hypoglycemia.
